Gastrointestinal symptoms after the substitution of sevelamer hydrochloride with lanthanum carbonate in Japanese patients undergoing hemodialysis

Publisher： Govi-Verlag

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.70, Iss.8, 2015-01, pp. : 522-526

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lanthanum Carbonate

By Tracy Swainston Harrison   Scott L.J.  

Drugs, Vol. 64, Iss. 9, 2004-01 ,pp. : 985-996

Adis International

Access to resources Recommend Favorite

Sevelamer Hydrochloride: A Review of its Use for Hyperphosphataemia in Patients with End-Stage Renal Disease on Haemodialysis

By Goldsmith David R.   Scott Lesley J.   Cvetković Risto S.   Plosker Greg L.  

Drugs, Vol. 68, Iss. 1, 2008-01 ,pp. : 85-104

Adis International

Access to resources Recommend Favorite

Lanthanum carbonate for the treatment of hyperphosphataemia in renal failure and dialysis patients

By Albaaj Fouad   Hutchison Alastair J  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 2, 2005-02 ,pp. : 319-328

Informa Healthcare

Access to resources Recommend Favorite

Lanthanum carbonate: profile report

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 9, 2004-09 ,pp. : 4-6

Adis International

Access to resources Recommend Favorite

SMC accepts sevelamer carbonate but rejects three others

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 627, 2011-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite